JP2021505201A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021505201A5 JP2021505201A5 JP2020550060A JP2020550060A JP2021505201A5 JP 2021505201 A5 JP2021505201 A5 JP 2021505201A5 JP 2020550060 A JP2020550060 A JP 2020550060A JP 2020550060 A JP2020550060 A JP 2020550060A JP 2021505201 A5 JP2021505201 A5 JP 2021505201A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- mutation
- acid position
- polymerase
- polymerase according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 35
- 230000035772 mutation Effects 0.000 claims description 32
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 7
- 108020004511 Recombinant DNA Proteins 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 101100117473 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) dbh gene Proteins 0.000 claims description 3
- 102220613594 Potassium voltage-gated channel subfamily D member 3_E79R_mutation Human genes 0.000 claims description 2
- 102220482854 Tyrosine-protein kinase receptor UFO_E63R_mutation Human genes 0.000 claims description 2
- 102200064130 rs137852229 Human genes 0.000 claims description 2
- 102200114232 rs62637020 Human genes 0.000 claims description 2
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 102200151424 rs5198 Human genes 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762597109P | 2017-12-11 | 2017-12-11 | |
| US62/597,109 | 2017-12-11 | ||
| US201862656696P | 2018-04-12 | 2018-04-12 | |
| US62/656,696 | 2018-04-12 | ||
| PCT/US2018/064794 WO2019118372A1 (en) | 2017-12-11 | 2018-12-10 | Dpo4 polymerase variants with improved accuracy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021505201A JP2021505201A (ja) | 2021-02-18 |
| JP2021505201A5 true JP2021505201A5 (enExample) | 2022-01-06 |
| JP7288457B2 JP7288457B2 (ja) | 2023-06-07 |
Family
ID=66819492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020550060A Active JP7288457B2 (ja) | 2017-12-11 | 2018-12-10 | 正確性が向上したｄｐｏ４ポリメラーゼバリアント |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11530392B2 (enExample) |
| EP (1) | EP3724323A4 (enExample) |
| JP (1) | JP7288457B2 (enExample) |
| CN (1) | CN111655846B (enExample) |
| AU (1) | AU2018383610B2 (enExample) |
| CA (1) | CA3084812A1 (enExample) |
| WO (1) | WO2019118372A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3904528A1 (en) | 2015-11-16 | 2021-11-03 | Stratos Genomics Inc. | Dp04 polymerase variants |
| ES2987024T3 (es) | 2017-05-04 | 2024-11-13 | Hoffmann La Roche | Variantes de polimerasa DP04 |
| US11530392B2 (en) | 2017-12-11 | 2022-12-20 | Stratos Genomics, Inc. | DPO4 polymerase variants with improved accuracy |
| WO2020236526A1 (en) | 2019-05-23 | 2020-11-26 | Stratos Genomics, Inc. | Translocation control elements, reporter codes, and further means for translocation control for use in nanopore sequencing |
| EP3994262A4 (en) * | 2019-06-26 | 2023-09-20 | Stratos Genomics Inc. | IMPROVEMENT OF THE POLYMERIZATION OF NUCLEIC ACIDS BY AROMATIC COMPOUNDS |
| WO2024083982A1 (en) | 2022-10-21 | 2024-04-25 | F. Hoffmann-La Roche Ag | Detection of modified nucleobases in nucleic acid samples |
| WO2025082960A1 (en) | 2023-10-18 | 2025-04-24 | F. Hoffmann-La Roche Ag | Dpo4 polymerase variants with improved properties |
| WO2025132780A2 (en) | 2023-12-22 | 2025-06-26 | F. Hoffmann-La Roche Ag | Methods and compositions for nucleic acid library and template preparation for duplexed sequencing by expansion |
| WO2025132779A2 (en) | 2023-12-22 | 2025-06-26 | F. Hoffmann-La Roche Ag | Methods and compositions for nucleic acid library and template preparation for duplexed sequencing by expansion |
| WO2025149478A1 (en) | 2024-01-12 | 2025-07-17 | F. Hoffmann-La Roche Ag | Compositions of modified nucleoside triphosphates |
| WO2025212586A1 (en) | 2024-04-02 | 2025-10-09 | Roche Sequencing Solutions, Inc. | High throughput inramolecular consensus reads |
| WO2026033006A1 (en) | 2024-08-07 | 2026-02-12 | Roche Sequencing Solutions, Inc. | Nickase-mediated linear amplification of library constructs for duplex sequencing |
| WO2026050121A1 (en) | 2024-08-30 | 2026-03-05 | Roche Sequencing Solutions, Inc. | Compositions for replicating a nucleic acid template |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0544824B1 (en) | 1990-07-27 | 1997-06-11 | Isis Pharmaceuticals, Inc. | Nuclease resistant, pyrimidine modified oligonucleotides that detect and modulate gene expression |
| US5432272A (en) | 1990-10-09 | 1995-07-11 | Benner; Steven A. | Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases |
| AU3222793A (en) | 1991-11-26 | 1993-06-28 | Gilead Sciences, Inc. | Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines |
| DK0691980T3 (da) | 1993-03-30 | 1997-12-29 | Sanofi Sa | 7-deazapurinmodifiderende oligonukleotider |
| AU6632094A (en) | 1993-04-19 | 1994-11-08 | Gilead Sciences, Inc. | Enhanced triple-helix and double-helix formation with oligomers containing modified purines |
| US6150510A (en) | 1995-11-06 | 2000-11-21 | Aventis Pharma Deutschland Gmbh | Modified oligonucleotides, their preparation and their use |
| AU2004288017B2 (en) | 2003-11-03 | 2009-10-08 | United Kingdom Research And Innovation | Polymerase |
| WO2005113760A2 (en) | 2004-05-20 | 2005-12-01 | The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services | Thermostable y-family polymerases and chimeras |
| AU2006330947B2 (en) | 2005-12-22 | 2012-04-12 | Pacific Biosciences Of California, Inc. | Polymerases for nucleotide analogue incorporation |
| AU2007309504B2 (en) | 2006-10-23 | 2012-09-13 | Pacific Biosciences Of California, Inc. | Polymerase enzymes and reagents for enhanced nucleic acid sequencing |
| DK2171088T3 (en) | 2007-06-19 | 2016-01-25 | Stratos Genomics Inc | Nucleic acid sequencing in a high yield by expansion |
| US8999676B2 (en) | 2008-03-31 | 2015-04-07 | Pacific Biosciences Of California, Inc. | Recombinant polymerases for improved single molecule sequencing |
| EP2850192B1 (en) * | 2012-05-16 | 2023-11-01 | APTARION biotech AG | Enzymatic synthesis of l-nucleic acids |
| CN105916992A (zh) * | 2013-11-20 | 2016-08-31 | 诺松制药股份公司 | 通过酶合成l-核酸 |
| HK1244813A1 (zh) | 2014-11-20 | 2018-08-17 | F. Hoffmann-La Roche Ag | 氰脲酸酯磷醯胺酯及其衍生物，其用途和合成 |
| US10526588B2 (en) * | 2015-05-14 | 2020-01-07 | Roche Sequencing Solutions, Inc. | Polymerase variants and uses thereof |
| EP3904528A1 (en) * | 2015-11-16 | 2021-11-03 | Stratos Genomics Inc. | Dp04 polymerase variants |
| CN106318924B (zh) * | 2016-10-26 | 2018-10-16 | 江南大学 | 一种催化dna合成延伸能力提高的dna聚合酶 |
| ES2987024T3 (es) * | 2017-05-04 | 2024-11-13 | Hoffmann La Roche | Variantes de polimerasa DP04 |
| US11530392B2 (en) | 2017-12-11 | 2022-12-20 | Stratos Genomics, Inc. | DPO4 polymerase variants with improved accuracy |
-
2018
- 2018-12-10 US US16/770,923 patent/US11530392B2/en active Active
- 2018-12-10 CA CA3084812A patent/CA3084812A1/en active Pending
- 2018-12-10 EP EP18888214.6A patent/EP3724323A4/en active Pending
- 2018-12-10 CN CN201880079698.7A patent/CN111655846B/zh active Active
- 2018-12-10 WO PCT/US2018/064794 patent/WO2019118372A1/en not_active Ceased
- 2018-12-10 JP JP2020550060A patent/JP7288457B2/ja active Active
- 2018-12-10 AU AU2018383610A patent/AU2018383610B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021505201A5 (enExample) | ||
| JP2017514522A5 (enExample) | ||
| Fedotova et al. | C2H2 zinc finger proteins: the largest but poorly explored family of higher eukaryotic transcription factors | |
| CL2019002280A1 (es) | Vectores virales, adenovirales y composiciones a base de una secuencia de ornitina transcarbamilasa humana (hotch) modificada genéticamente y su uso en el tratamiento de deficiencia de la otc. (divisional solicitud 201602235) | |
| JP2017018125A5 (enExample) | ||
| JP2018138049A5 (enExample) | ||
| NZ602351A (en) | Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184 : vip3a insecticidal proteins from bacillus thuringiensis and methods for their use | |
| JP2019122392A5 (enExample) | ||
| JP2019500414A5 (enExample) | ||
| JP2012522501A5 (enExample) | ||
| JP2017212998A5 (enExample) | ||
| JP2018529331A5 (enExample) | ||
| JP2013517781A5 (enExample) | ||
| JP2015096070A5 (enExample) | ||
| JP2014504851A5 (enExample) | ||
| JP2008295444A5 (enExample) | ||
| JP2016527891A5 (enExample) | ||
| HRP20241180T1 (hr) | Modificirani faktor ix, te pripravci, postupci i upotreba za prijenos gena u stanice, organe i tkiva | |
| JP2011224002A5 (enExample) | ||
| JP2019532674A5 (enExample) | ||
| JP2013530689A5 (enExample) | ||
| JP2019536462A5 (enExample) | ||
| JP2015514132A5 (enExample) | ||
| JP2016503434A5 (enExample) | ||
| JP2014507146A5 (enExample) |